SCHEMBL7048474

SCHEMBL7048474

N#Cc1cccc(CC(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.60
MAOB P27338 5/20 0.60
TTR P02766 5/20 0.47
GPR35 Q9HC97 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
GMNN O75496 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
THRB P10828 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
MAPK1 P28482 1/20 0.47
RECQL P46063 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nebicapone SCHEMBL29379610 0.82 TTR (0.56) MAOAMAOBTTRGPR35KDM4E
Nebicapone SCHEMBL132167 0.82 TTR (0.56) MAOAMAOBTTRGPR35KDM4E
SCHEMBL7046492 0.82 TTR (0.55) MAOAMAOBTTRGPR35KDM4E
SCHEMBL27494691 0.79 MAOA (0.49) MAOAMAOBTTRGPR35KDM4E
SCHEMBL7046444 0.77 TTR (0.51) MAOAMAOBTTRGPR35KDM4E
SCHEMBL7046913 0.77 TTR (0.50) MAOAMAOBTTRGPR35KDM4E
SCHEMBL7198182 0.76 CRHBP (0.52) MAOAMAOBTTRGPR35KDM4E
SCHEMBL7046272 0.76 TTR (0.53) MAOAMAOBTTRGPR35KDM4E
SCHEMBL7045653 0.75 TTR (0.67) MAOAMAOBTTRGPR35KDM4E
SCHEMBL7046543 0.75 TTR (0.58) TTRGPR35KDM4EMEN1GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1010688-B1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them PORTELA & CA SA (PT) 2003-04-09 EP disclosed
US-6512136-B1 Hypotensive, antiedemic agents; gastrointestinal disorders; Parkinson*s disease treatment PORTELA & C.A., S.A. (PT) 2003-01-28 US disclosed
EP-1010688-A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them Portela & Ca., S.A. (PT) 2000-06-21 EP disclosed